SHANGHAI UNIVERSAL BIOTECH CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.93 CNY | -4.19% |
|
-5.26% | -27.30% |
| Sales 2021 | 1.11B 153M | Sales 2022 | 1.2B 165M | Capitalization | 3.96B 548M |
|---|---|---|---|---|---|
| Net income 2021 | 109M 15.06M | Net income 2022 | 106M 14.65M | EV / Sales 2021 | 6.36 x |
| Net cash position 2021 | 1.87B 258M | Net cash position 2022 | 1.58B 218M | EV / Sales 2022 | 1.99 x |
| P/E ratio 2021 |
62
x | P/E ratio 2022 |
37.2
x | Employees | 688 |
| Yield 2021 |
0.49% | Yield 2022 |
1.97% | Free-Float | 30.51% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.19% | ||
| 1 week | -5.26% | ||
| Current month | -7.33% | ||
| 1 month | -10.16% | ||
| 3 months | -23.27% | ||
| 6 months | -35.81% | ||
| Current year | -27.30% |
1 week
27.58
30.73
1 month
27.5832.32
Current year
22.8138.93
1 year
22.8151.65
3 years
22.81136.00
5 years
22.81136.00
10 years
22.81136.00
| Managers | Title | Age | Since |
|---|---|---|---|
Zhao Wu Leng
CEO | Chief Executive Officer | 54 | 04-09-30 |
Min Tang
DFI | Director of Finance/CFO | 44 | 19-08-31 |
Yan Fang Qi
COO | Chief Operating Officer | 44 | 10-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lei Shi
BRD | Director/Board Member | 66 | 20-04-15 |
Jiang Hua Mei
BRD | Director/Board Member | 46 | 18-10-31 |
Yun Chen
BRD | Director/Board Member | 38 | 15-10-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-15 | 27.93 | -4.19% | 779,152 |
| 24-04-12 | 29.15 | -1.29% | 374,000 |
| 24-04-11 | 29.53 | +0.14% | 428,800 |
| 24-04-10 | 29.49 | -4.00% | 605,489 |
| 24-04-09 | 30.72 | +4.21% | 728,700 |
End-of-day quote Shenzhen S.E., April 14, 2024
More quotes
Shanghai Universal Biotech Co Ltd is a China-based company mainly engaged in the supply of life science reagent products. The Company is also engaged in the supply of life science instruments and consumables and comprehensive technical services. The products supplied by the Company are mainly third-party brand products, supplemented by independent brand products. The life science reagents mainly include immunological reagents based on antibodies and antibody related reagents, as well as molecular biology reagents, cell biology reagents and biochemical reagents. The life science instruments and consumables include detection and analysis and sample preparation. The comprehensive technical services include experimental services, technical support services and other services.
Sector
Pharmaceuticals
Calendar
2024-04-22
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -27.30% | 334M | |
| +14.05% | 68.68B | |
| +3.53% | 7.94B | |
| -4.45% | 7.86B | |
| -28.85% | 7.13B | |
| +1.04% | 4.59B | |
| +19.12% | 4.39B | |
| 0.00% | 4.06B | |
| -3.64% | 3.85B | |
| +22.19% | 3.65B |
- Stock Market
- Equities
- 301166 Stock
